Group 1 - Abbott hosted a seminar on women's health management during the 8th China International Import Expo, focusing on fertility protection and menopause health management [1] - The National Health Commission emphasized the importance of improving reproductive health services to enhance birth quality and public happiness [1] - Experts recommend that women with fertility plans undergo scientific assessments and seek support when facing physiological challenges, with 60% of infertility patients able to conceive naturally through standardized treatment [1] Group 2 - The aging population in China is leading to increased attention on menopause health management, with over 280 million women expected to enter menopause by 2030 [2] - Decreased estrogen and progesterone levels during menopause can lead to various symptoms and increased risks of chronic diseases such as osteoporosis and cardiovascular issues [2] - Menopause management is crucial for women's long-term health, with lifestyle adjustments and medical interventions like hormone therapy available to alleviate symptoms and improve quality of life [2]

11月7日，在进博会期间，全球领先的医疗健康公司雅培举办"臻爱女性 全程守护"女性全生命周期健康 管理专家研讨会，邀请到多位临床专家，以及来自国家卫健委妇幼中心的专家，聚焦生育力保护与更年 期健康管理，共同倡导建设生育友好型社会。 国家卫健委提出，在促进人口高质量发展方面，要建设生育友好型社会，优化生育支持政策。国家卫生 健康委妇幼健康中心生殖健康部负责人马艺表示："围绕人口高质量发展目标，我们通过提供更完善的 生殖健康服务，切实保障群众生育权益，提升出生人口素质，增强人民群众的幸福感。" 国家卫生健康委妇幼健康中心生殖健康部负责人马艺。主办方供图 雅培举办"臻爱女性 全程守护"女性全生命周期健康管理专家研讨会。主办方供图 生育年龄推迟成挑战，专家建议尽早评估生育力 数据显示，中国不孕症患病率已上升至17.6%。在女性生殖健康领域，激素水平的平衡是维持正常生理 功能的关键。其中，孕激素作为关键调节激素，其分泌不足所导致的黄体功能不全，占不孕症病因的 5%～10%。 复旦大学附属中山医院生殖中心负责人董曦教授在研讨会上指出："以孕酮为例，作为人体内关键的天 然孕激素，含量不足可能引发痛经、月经周期不规律、黄体不 ...

Core Insights - The collaboration between Yiling Pharmaceutical and JD Health aims to enhance the "Anti-Aging Center" digital marketing initiative, leveraging both companies' strengths in their respective fields [1][2] Group 1: Collaboration Details - The partnership focuses on utilizing JD Health's platform traffic and digital marketing capabilities to create a comprehensive platform for expert education, authoritative information, and anti-aging resources [2] - Yiling Pharmaceutical will leverage its expertise in traditional Chinese medicine (TCM) research and product development, particularly promoting its core product, the Eight Sons Kidney Capsule [2][3] Group 2: Product Focus and Market Strategy - The collaboration will emphasize the unique benefits of the Eight Sons Kidney Capsule, particularly in women's health, addressing menopausal symptoms, and promoting a youthful appearance [2][3] - Both companies will conduct real-world studies and data analysis to reinforce Yiling Pharmaceutical's position as a leader in the scientific and data-driven TCM field [3] Group 3: Future Vision and Goals - The partnership is seen as a significant step towards digital transformation for Yiling Pharmaceutical, aiming to provide precise and scientific health solutions for women [4] - The collaboration aligns with the "Healthy China 2030" strategy, focusing on menopause health management and enhancing the overall health service ecosystem [4]